Cynthia Behling
Impact in
- Hepatology top 0.1%
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Epidemiology top 0.02%
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 57
- Liver Disease Diagnosis and Treatment 54
- Hepatology 15
- Liver Diseases and Immunity 7
- Liver Disease and Transplantation 6
- Hepatitis C virus research 4
- Co-authors
- Arun J. Sanyal (16 shared papers)David E. Kleiner (13 shared papers)Mark L. Van Natta (7 shared papers)Oscar W. Cummings (10 shared papers)Melissa J. Contos (4 shared papers)Matthew M. Yeh (5 shared papers)Aynur Ünalp–Arida (2 shared papers)Arthur J. McCullough (3 shared papers)
- Journals
- Hepatology (14 papers)Journal of Hepatology (9 papers)Gastroenterology (5 papers)Alimentary Pharmacology & Therapeutics (4 papers)Journal of Clinical Gastroenterology (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Cynthia Behling
91 papers receiving 15.8k citations
Cynthia Behling's Hit Papers
Peers
Comparison fields: 5 of 136
- Hepatology 3.1k
- Epidemiology 10.7k
- Endocrinology, Diabetes and Metabolism 3.0k
- Pathology and Forensic Medicine 1.2k
- Cell Biology 810
Countries citing papers authored by Cynthia Behling
This map shows the geographic impact of Cynthia Behling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cynthia Behling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cynthia Behling more than expected).
Fields of papers citing papers by Cynthia Behling
This network shows the impact of papers produced by Cynthia Behling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cynthia Behling. The network helps show where Cynthia Behling may publish in the future.
Co-authors
The 25 scholars most cited alongside Cynthia Behling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Design and validation of a histological scoring system for nonalcoholic fatty liver disease† Hit paper breakdown → | 2005 | 8495 |
| 2 | Prevalence of Fatty Liver in Children and Adolescents Hit paper breakdown → | 2006 | 1128 |
| 3 | Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2021 | 699 |
| 4 | Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * # Hit paper breakdown → | 2005 | 562 |
| 5 | Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer Hit paper breakdown → | 2001 | 546 |
| 6 | 2003 | 393 | |
| 7 | Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study Hit paper breakdown → | 2014 | 375 |
| 8 | 2004 | 354 | |
| 9 | 2003 | 298 | |
| 10 | Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2019 | 279 |
| 11 | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial Hit paper breakdown → | 2021 | 271 |
| 12 | Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial Hit paper breakdown → | 2023 | 171 |
| 13 | 2006 | 153 | |
| 14 | 2013 | 147 | |
| 15 | 2010 | 144 | |
| 16 | 2014 | 142 | |
| 17 | 2018 | 115 | |
| 18 | 2020 | 110 | |
| 19 | 2020 | 100 | |
| 20 | 2007 | 94 |
About Cynthia Behling
Cynthia Behling is a scholar working on Epidemiology, Hepatology, Surgery, Molecular Biology and Oncology, having authored 97 papers that have together received 16.1k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (54 papers), Liver Diseases and Immunity (7 papers), Liver Disease and Transplantation (6 papers), Hepatitis C virus research (4 papers), Fibroblast Growth Factor Research (3 papers), Pancreatitis Pathology and Treatment (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Transplantation: Methods and Outcomes (3 papers). The work is most often cited by research in Hepatology (3.1k citations), Epidemiology (10.7k citations), Endocrinology, Diabetes and Metabolism (3.0k citations), Pathology and Forensic Medicine (1.2k citations) and Cell Biology (810 citations). Cynthia Behling has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Arun J. Sanyal, David E. Kleiner, Mark L. Van Natta, Oscar W. Cummings, Melissa J. Contos, Matthew M. Yeh, Aynur Ünalp–Arida, Arthur J. McCullough, Elizabeth M. Brunt and Michael Torbenson. Their work appears in journals such as Hepatology, Journal of Hepatology, Gastroenterology, Alimentary Pharmacology & Therapeutics and Journal of Clinical Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.